rs116222916
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_014425.5(INVS):āc.2116A>Gā(p.Arg706Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000681 in 1,614,170 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_014425.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
INVS | NM_014425.5 | c.2116A>G | p.Arg706Gly | missense_variant | 14/17 | ENST00000262457.7 | |
INVS | NM_001318381.2 | c.1828A>G | p.Arg610Gly | missense_variant | 15/18 | ||
INVS | NM_001318382.2 | c.1138A>G | p.Arg380Gly | missense_variant | 14/17 | ||
INVS | NR_134606.2 | n.2267-2A>G | splice_acceptor_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
INVS | ENST00000262457.7 | c.2116A>G | p.Arg706Gly | missense_variant | 14/17 | 1 | NM_014425.5 | A2 | |
INVS | ENST00000262456.6 | c.2116A>G | p.Arg706Gly | missense_variant | 14/18 | 5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 536AN: 152158Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.000923 AC: 232AN: 251442Hom.: 1 AF XY: 0.000795 AC XY: 108AN XY: 135888
GnomAD4 exome AF: 0.000382 AC: 558AN: 1461894Hom.: 3 Cov.: 31 AF XY: 0.000355 AC XY: 258AN XY: 727248
GnomAD4 genome AF: 0.00355 AC: 541AN: 152276Hom.: 4 Cov.: 32 AF XY: 0.00357 AC XY: 266AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Nephronophthisis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Infantile nephronophthisis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at